Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TVGN
TVGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TVGN News
Tevogen Evaluates Potential Special Cash Dividend
Jan 30 2026
Newsfilter
Tevogen Modifies Long-Term Incentive Program to Drive Growth
Jan 29 2026
Newsfilter
Tevogen Bio Achieves Multiple Milestones in 2025, Expands Cell Therapy Pipeline
Jan 12 2026
Newsfilter
Tevogen Founder Donates 230,000 Shares to Support Education Initiatives
Dec 22 2025
Globenewswire
Tevogen CEO Donates 50,000 Shares to Support Local Fire Company
Dec 19 2025
Newsfilter
Tevogen CEO Donates 50,000 Shares to Support Local Fire Company
Dec 19 2025
Globenewswire
Tevogen Founder Donates 230,000 Shares to Local Police Benevolent Association
Dec 11 2025
Globenewswire
Tevogen CEO Donates 230,000 Shares of Common Stock to Support Local Law Enforcement
Dec 11 2025
Yahoo Finance
Tevogen Bio Recognizes Dr. Curtis Patton, Aims for Over $1 Billion Revenue
Dec 09 2025
Globenewswire
Tevogen Bio Honors Founding Director Curtis Patton with Yale Portrait
Dec 09 2025
Newsfilter
Tevogen Named to 2025 NJ Power List, Anticipates $1 Billion First-Year Revenue
Dec 08 2025
Newsfilter
Heartbeam Shares Surge Approximately 43%; Check Out 20 Stocks Making Moves in Premarket Trading
Nov 28 2025
Benzinga
Tevogen Addresses Financial Report, Emphasizing Robust Capital Efficiency and Minimal Cash Burn
Nov 03 2025
Newsfilter
Tevogen Executives Connect with Business and Community Leaders to Showcase Recent Achievements
Oct 29 2025
Newsfilter
Tevogen Provides Update on TVGN 489 Amid Increasing Interest from Long COVID Patients
Oct 15 2025
Newsfilter
Tevogen Achieves Significant Progress in AI Efforts to Improve T Cell–Based Therapies with 100x Expansion of PredicTcell™ Beta Data
Sep 25 2025
Newsfilter
Show More News
